$SCHL

Scholastic Corporation Q4 2026 Earnings Call Summary

Scholastic (Scholastic Corporation) reported a 32% rise in adjusted operating income attributed to a multiyear efficiency and integrated publishing and school growth transformation. Management said Book Fairs growth was driven by higher fair counts and digital tools. Fiscal 2027 guidance calls for 2% to 4% revenue growth and higher adjusted EBITDA, with capital returns supported by sale-leasebacks and leverage targets of 2x to 2.5x.

Original reporting
Published Jul 25, 2026, 2:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 25, 2026, 2:48 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Scholastic Corporation Q4 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$SCHLNeutralMed
01

Why it matters

Traders can update SCHL’s forward revenue and capital-return expectations using the disclosed fiscal 2027 guidance range, leverage framework, and dividend increase, while monitoring Education stabilization assumptions and AI-content competitive dynamics.

02

Market read

Fresh fiscal 2027 guidance and capital-return details can drive near-term positioning in SCHL, especially for investors focused on revenue growth durability and shareholder yield.

03

What to watch

Sale-leaseback effects (higher lease expense, lost rental income) may continue to distort comparability, and Entertainment contracted revenue exceeding 100% of prior-year total may not fully translate into incremental profitability.

Relevance 7/10Novelty 6/10Timing: ahead of fiscal 2027 positioning after the earnings call

Background

The article summarizes Scholastic’s Q4 2026 earnings call, emphasizing a multiyear transformation, segment integration, and capital deployment via sale-leasebacks and buybacks.

Company-level read

Ticker impact

$SCHLNeutralMedium confidence
Context

Scholastic guides fiscal 2027 revenue growth of 2% to 4% and frames it as an execution year after a 32% adjusted operating income rise.

Expected impact

Moderate near-term repricing possible as traders weigh 2% to 4% growth against segment stabilization assumptions and higher dividend.

Evidence & confidence

The article includes explicit fiscal 2027 revenue guidance, leverage framework, and a 25% dividend increase, which are direct inputs to valuation and positioning. However, it lacks the actual Q4 print numbers and consensus comparisons, limiting precision.

Market effects

Read-across to education publishing and children’s media demand, especially around district funding volatility and digital tool adoption.

Primarily US education spending dynamics tied to district funding patterns.

Limited direct global impact; content franchises (e.g., Hunger Games, Harry Potter, Dog Man) may have international demand but the guidance is framed around US segment conditions.

Counterpoint

The 2% to 4% growth outlook may be conservative if Education stabilization takes longer, and the AI-content quality overhang could pressure margins or increase marketing costs.

Key entities

  • Scholastic Corporation

    Provides fiscal 2027 revenue guidance (2% to 4%), discusses segment drivers, and announces a 25% regular quarterly dividend increase.

  • The Children’s Book Group (CBG)

    Managed as a unified platform to align publishing, merchandising, and distribution.

  • 9 Story Media Group

    Integration highlighted as expanding content development and monetization of Scholastic IP across formats.

Related articles

$SCHLMed

SCHOLASTIC CORP (SCHL): Results of Operations and Financial Condition

SCHOLASTIC CORP (SCHL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 fy26q4pressrelease.htm EX-99.1 Document Scholastic Reports Fourth Quarter and Fiscal 2026 Results Fiscal 2026 Operating Income of $15.2 Million; Adjusted EBITDA of $151.5 Million, Up 4%, in Line With Guidance Returned Over $285 Million to Shareholders During Fiscal Year

$DRIMedAI 8/10

DRI Healthcare Reports Second Quarter 2026 Results and New Board Appointment

DRI Healthcare Trust (TSX: DHT.UN, DHT.U) reported Q2 2026 results for the quarter ended June 30, 2026: total income $50.1M, total cash receipts $46.5M, and adjusted EBITDA $42.6M. It repurchased 89,513 units at $11.65 and paid a $0.11/unit distribution. After quarter-end, it exercised a put option on Ekterly for about $178M and received FDA approval for Lumvoa (veligrotug), triggering $75M milestone payments.

$LGNDMed

Ligand Pharmaceuticals Incorporated Q2 2026 Earnings Call Summary

Ligand Pharmaceuticals reported Q2 2026 results and discussed its XOMA Royalty acquisition, adding 120+ assets and extending cash flow duration through 2040. Management cited 32% YoY royalty revenue growth and expects 2026 royalty revenue of $225M-$250M with cash opex halved since 2022. Ligand issued a $700M zero-coupon convertible, raised 2026 adjusted EPS guidance to $9.00-$9.50, and expects accretion from XOMA in 2H26 and 2027.

$KDPMed

Keurig Dr Pepper Inc. Q2 2026 Earnings Call Summary

Keurig Dr Pepper reported Q2 2026 results that exceeded expectations, citing double-digit U.S. Refreshment Beverages growth and day-one integration of JDE Peet's. Dr Pepper Zero Sugar grew 30% in retail sales and energy reached 9% market share. U.S. Coffee faced margin pressure from hedging and tariffs. KDP reaffirmed low double-digit EPS growth for 2026 and low-double-digit legacy growth at the high end of 4% to 6%.